Chronic Pain Data Epilepsy Topical 
Cannabis Law Report
JUNE 7, 2022
On the contrary, researchers are leaning more towards CBD as a beneficial chemical with therapeutic effects on various physical and mental health problems, from anxiety to chronic pain. Relieves Chronic Pain. Other studies found encouraging results on neuropathic pain, arthritis pain, and multiple sclerosis.
Canna Care Docs
DECEMBER 16, 2020
Medical cannabis is available in any of the same forms as recreational cannabis—as smokable flower, edibles , tinctures, topical products , and more. Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain. Could medical cannabis help you find the “new you” in 2021?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 20, 2021
Data To Support Regulatory Filings in the United States. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., First Patient Expected to be Enrolled by Q2 of 2022.
Cannabis Law Report
DECEMBER 8, 2021
This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials. Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Forward-Looking Statement.
Cannabis Law Report
NOVEMBER 10, 2021
The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. In October 2021, Virpax announced that a $1.87 About Virpax Pharmaceuticals.
CannaTech
SEPTEMBER 16, 2018
Many healthcare practitioners possess a knowledge gap about cannabis, as their medical school curriculum didn’t include any information on the topic. What was once an illegal drug is slowly being heralded as an alternative to opioids, or a way to manage rare forms of childhood epilepsy.
Cannabis Law Report
OCTOBER 6, 2021
Preliminary in-vitro, ex-vivo, and in-vivo data demonstrated that AnQlar inhibits replication of SARS-CoV-2 and may inhibit viral spread as well as viral brain load at non-toxic concentrations. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain.
Expert insights. Personalized for you.
52 
Let's personalize your content